Birchview Capital’s Neuropace NPCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$183K Hold
16,442
0.18% 59
2025
Q1
$202K Buy
16,442
+6,442
+64% +$79.2K 0.18% 53
2024
Q4
$112K Buy
+10,000
New +$112K 0.09% 63